Molecular subgroups of atypical teratoid rhabdoid tumours in children: An integrated genomic and clinicopathological analysis

The Lancet Oncology

Volumn 16, Issue 5, 2015, Pages 569-582

  Torchia, Jonathon ^a,b,c   Picard, Daniel ^a,b,c   Lafay Cousin, Lucie ^d   Hawkins, Cynthia E ^b,c   Kim, Seung Ki ^f   Letourneau, Louis ^e   Ra, Young Shin ^g   Ho, King Ching ^a,b   Chan, Tiffany Sin Yu ^a,b,c   Sin Chan, Patrick ^a,b,c   Dunham, Christopher P ^h   Yip, Stephen ⁱ   Ng, Ho keung ^j   Lu, Jian Qiang ^k   Albrecht, Steffen ^l   Pimentel, José ^m   Chan, Jennifer A ^d   Somers, Gino R ^b,c   Zielenska, Maria ^b,c   Faria, Claudia C ⁿ   Roque, Lucia ^o   Baskin, Berivan ^p   Birks, Diane ^q   Foreman, Nick ^q   Strother, Douglas ^d   Klekner, Almos ^r   Garami, Miklos ^s   Hauser, Peter ^s   Hortobágyi, Tibor ^t   Bognár, Laszló ^r   Wilson, Beverly ^u   Hukin, Juliette ^v   Carret, Anne Sophie ^w   Van Meter, Timothy E ^x   Nakamura, Hideo ^y   Toledano, Helen ^z   Fried, Iris ^aa   Fults, Daniel ^ab   Wataya, Takafumi ^ac   Fryer, Chris ^v   Eisenstat, David D ^u   Scheineman, Katrin ^ad   Johnston, Donna ^ae   Michaud, Jean ^af   Zelcer, Shayna ^ag   Hammond, Robert ^ah   Ramsay, David A ^ai   Fleming, Adam J ^ad   Lulla, Rishi R ^aj   Fangusaro, Jason R ^aj   Sirachainan, Nongnuch ^ak   Larbcharoensub, Noppadol ^ak   Hongeng, Suradej ^ak   Barakzai, Muhammad Abrar ^al   Montpetit, Alexandre ^e   Stephens, Derek ^b   Grundy, Richard G ^am   Schüller, Ulrich ^an   Nicolaides, Theodore ^ao   Tihan, Tarik ^ao   Phillips, Joanna ^ap   Taylor, Michael D ^b,c   Rutka, James T ^b,c   Dirks, Peter ^b,c   Bader, Gary D ^c   Warmuth Metz, Monika ^aq   Rutkowski, Stefan ^ar   Pietsch, Torsten ^as   Judkins, Alexander R ^at   Jabado, Nada ^e   Bouffet, Eric ^a   Huang, Annie ^a,b,c   more..

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f Seoul National University Children's Hospital   (South Korea)

^g Asan Medical Center   (South Korea)

^h CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

ⁱ VANCOUVER GENERAL HOSPITAL   (Canada)

^j CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^k UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^l MONTREAL CHILDREN S HOSPITAL   (Canada)

^m HOSPITAL DE SANTA MARIA   (Portugal)

ⁿ INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^o Portuguese Cancer Institute   (Portugal)

^p UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^q University of Colorado Denver and Children s Hospital Colorado   (United States)

^r UNIVERSITY OF DEBRECEN   (Hungary)

^s SEMMELWEIS UNIVERSITY   (Hungary)

^t UNIVERSITY OF SZEGED   (Hungary)

^u UNIVERSITY OF ALBERTA   (Canada)

^v UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^w UNIVERSITY OF MONTREAL   (Canada)

^x VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^y KUMAMOTO UNIVERSITY   (Japan)

^z Schneider's Children's Hospital   (Israel)

^aa HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^ab UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^ac SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

^ad MCMASTER UNIVERSITY   (Canada)

^ae UNIVERSITY OF OTTAWA   (Canada)

^af CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^ag CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^ah UNIVERSITY OF WESTERN ONTARIO   (Canada)

^ai LONDON HEALTH SCIENCES CENTRE   (Canada)

^aj CHILDREN'S MEMORIAL HOSPITAL   (United States)

^ak MAHIDOL UNIVERSITY   (Thailand)

^al AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^am UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^an UNIVERSITY OF MUNICH   (Germany)

^ao UNIVERSITY OF CALIFORNIA   (United States)

^ap UNIVERSITY OF CALIFORNIA   (United States)

^aq UNIVERSITY OF WÜRZBURG   (Germany)

^ar UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^as UNIVERSITY HOSPITAL BONN   (Germany)

^at CHILDREN S HOSPITAL LOS ANGELES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MOLECULAR MARKER; NOTCH RECEPTOR; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION FACTOR MASH1; ASCL1 PROTEIN, HUMAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR;

ARTICLE; ATYPICAL TERATOID RHABDOID TUMOR; BRAIN SURGERY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHILD; COHORT ANALYSIS; CORRELATION ANALYSIS; FEMALE; GENE DOSAGE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; TUMOR LOCALIZATION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; INFANT; PATHOLOGY; PROGNOSIS; RHABDOID TUMOR; TERATOMA;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; PROGNOSIS; RECEPTORS, NOTCH; RHABDOID TUMOR; RISK FACTORS; SIGNAL TRANSDUCTION; TERATOMA;

EID: 84933676892     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)70114-2     Document Type: Article

References (47)

1. Hilden JM Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 2004, 22:2877-2884.
2. Zaky W, Dhall G, Ji L, et al. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. Pediatr Blood Cancer 2014, 61:95-101.
3. Tekautz TM Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 2005, 23:1491-1499.
4. Chi SN, Zimmerman MA, Yao X, et al. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 2008, 27:385-389.
5. Lafay-Cousin L, Hawkins C, Carret AS, et al. Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience. Eur J Cancer 2012, 48:353-359.
6. Nicolaides T, Tihan T, Horn B, Biegel J, Prados M, Banerjee A High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol 2010, 98:117-123.
7. Slavc I, Chocholous M, Leiss U, et al. Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012. Cancer Med 2014, 3:91-100.
8. Finkelstein-Shechter T, Gassas A, Mabbott D, et al. Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy. J Pediatr Hematol Oncol 2010, 32:e182-e186.
9. Versteege I, Sévenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998, 394:203-206.
10. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002, 8:3461-3467.
11. Bourdeaut F, Lequin D, Brugieres L, et al. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res 2011, 17:31-38.
12. Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 2011, 56:7-15.
13. Sévenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 1999, 65:1342-1348.
14. Yoo AS, Crabtree GR ATP-dependent chromatin remodeling in neural development. Curr Opin Neurobiol 2009, 19:120-126.
15. Klochendler-Yeivin A, Fiette L, Barra J, Muchardt C, Babinet C, Yaniv M The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep 2000, 1:500-506.
16. Roberts CW, Galusha SA, McMenamin ME, Fletcher CD, Orkin SH Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc Natl Acad Sci USA 2000, 97:13796-13800.
17. Roberts CW, Leroux MM, Fleming MD, Orkin SH Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell 2002, 2:415-425.
18. Lee RS, Stewart C, Carter SL, et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest 2012, 122:2983-2988.
19. Kieran MW, Roberts CW, Chi SN, et al. Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors. Pediatr Blood Cancer 2012, 59:1155-1157.
20. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114:97-109.
21. von Hoff K, Hinkes B, Dannenmann-Stern E, et al. Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer 2011, 57:978-985.
22. Johnson WE, Li C, Rabinovic A Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8:118-127.
23. Venneti S, Le P, Martinez D, et al. p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors. J Neuropathol Exp Neurol 2011, 70:596-609.
24. Liu Y, Hayes DN, Nobel A, Marron JS Statistical significance of clustering for high-dimension, low-sample size data. J Am Stat Assoc 2008, 103:1281-1293.
25. Sharifi K, Morihiro Y, Maekawa M, et al. FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation. Histochem Cell Biol 2011, 136:501-513.
26. Nelson BR, Hartman BH, Ray CA, Hayashi T, Bermingham-McDonogh O, Reh TA Acheate-scute like 1 (Ascl1) is required for normal delta-like (Dll) gene expression and notch signaling during retinal development. Dev Dyn 2009, 238:2163-2178.
27. Chillakuri CR, Sheppard D, Lea SM, Handford PA Notch receptor-ligand binding and activation: insights from molecular studies. Semin Cell Dev Biol 2012, 23:421-428.
28. Chau JF, Jia D, Wang Z, et al. A crucial role for bone morphogenetic protein-Smad1 signalling in the DNA damage response. Nat Commun 2012, 3:836.
29. Dufour C, Beaugrand A, Le Deley MC, et al. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study. Cancer 2012, 118:3812-3821.
30. Reinhard H, Reinert J, Beier R, et al. Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in Germany. Oncol Rep 2008, 19:819-823.
31. Sultan I, Qaddoumi I, Rodriguez-Galindo C, Nassan AA, Ghandour K, Al-Hussaini M Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors. Pediatr Blood Cancer 2010, 54:35-40.
32. Bruggers CS, Bleyl SB, Pysher T, et al. Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. Pediatr Blood Cancer 2011, 56:1026-1031.
33. Squire SE, Chan MD, Marcus KJ Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy. J Neurooncol 2007, 81:97-111.
34. Pai Panandiker AS, Merchant TE, Beltran C, et al. Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system. Int J Radiat Oncol Biol Phys 2012, 82:1756-1763.
35. Birks DK, Donson AM, Patel PR, et al. High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival. Neuro Oncol 2011, 13:1296-1307.
36. Roy A, Gonzalez-Gomez M, Pierani A, Meyer G, Tole S Lhx2 regulates the development of the forebrain hem system. Cereb Cortex 2013, 24:1361-1372.
37. Cecconi F, Proetzel G, Alvarez-Bolado G, Jay D, Gruss P Expression of Meis2, a Knotted-related murine homeobox gene, indicates a role in the differentiation of the forebrain and the somitic mesoderm. Dev Dyn 1997, 210:184-190.
38. Kim HJ, McMillan E, Han F, Svendsen CN Regionally specified human neural progenitor cells derived from the mesencephalon and forebrain undergo increased neurogenesis following overexpression of ASCL1. Stem Cells 2009, 27:390-398.
39. Elms P, Siggers P, Napper D, Greenfield A, Arkell R Zic2 is required for neural crest formation and hindbrain patterning during mouse development. Dev Biol 2003, 264:391-406.
40. Wortham M, Jin G, Sun JL, Bigner DD, He Y, Yan H Aberrant Otx2 expression enhances migration and induces ectopic proliferation of hindbrain neuronal progenitor cells. PLoS One 2012, 7:e36211.
41. Gadd S, Sredni ST, Huang C-C, Perlman EJ Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets. Lab Invest 2010, 90:724-738. Group RTCotCasO.
42. Hasan A, Palumbo M, Atkinson J, et al. Treatment-related morbidity in atypical teratoid/rhabdoid tumor: multifocal necrotizing leukoencephalopathy. Pediatr Neurosurg 2011, 47:7-14.
43. Venkataraman S, Alimova I, Tello T, et al. Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells. J Neurooncol 2012, 107:517-526.
44. Smith ME, Cimica V, Chinni S, et al. Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1. Proc Natl Acad Sci USA 2011, 108:319-324.
45. Cimica V, Smith ME, Zhang Z, Mathur D, Mani S, Kalpana GV Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen. BMC Cancer 2010, 10:634.
46. Lunenburger H, Lanvers-Kaminsky C, Lechtape B, Fruhwald MC Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines. Anticancer Drugs 2010, 21:514-522.
47. D'Cunja J, Shalaby T, Rivera P, et al. Antisense treatment of IGF-IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumours cells. Eur J Cancer 2007, 43:1581-1589.